Wanebo H J, Cole B, Chung M, Vezeridis M, Schepps B, Fulton J, Bland K
Department of Surgery, Brown University at Roger Williams Medical Center, Rhode Island Hospital, Providence, USA.
Ann Surg. 1997 May;225(5):579-86; discussion 586-9. doi: 10.1097/00000658-199705000-00014.
The suggestion that breast cancer management is compromised in elderly patients had prompted our review of the results of policies regarding screening and early detection of breast cancer and the adequacy of primary treatment in older women (> or = 65 years of age) compared to younger women (40 to 64 years of age).
Although breast cancer in elderly patients is considered biologically less aggressive than similar staged cancer in younger counterparts, outcome still is a matter of stage and adequate treatment of primary cancer. For many reasons, physicians appear reluctant to treat elderly patients according to the same standards used for younger patients. There is even government-mandated alterations in early detection programs. Thus, since 1993, Medicare has mandated screening mammography on a biennial basis for women older than 65 year of age compared to the current accepted standard of yearly mammograms for women older than 50 years of age. Using State Health Department and tumor registry data, the authors reviewed screening practice and management of elderly patients with primary breast cancer to determine the effects of age on screening, detection policies (as reflected in stage at diagnosis), treatment strategies, and outcome.
Data were analyzed from 5962 patients with breast cancer recorded in the state-wide Tumor Registry of the Hospital Association of Rhoda Island between 1987 and 1995. The focus of the data collection was nine institutions with established tumor registries using AJCC classified tumor data. Additional data were provided by the State Health Department on screening mammography practice in 2536 women during the years 1987, 1989, and 1995.
The frequency of mammographic screening for all averaged 40% in 1987, 52% in 1987, and 63% in 1995. In the 65-year-old and older patients, the frequency of screening was 34% in 1987, 45% in 1989, and 48% in 1995, whereas in the 40- to 49-year-old age group, the frequency of mammography was 47% in 1987, 61% in 1989, and 74% in 1995 (p < 0.001). There was a lower detection rate of preinvasive cancer in the 65-year-old and older patients, 8.8% versus 13.7% in patients within the 40- to 64-year-old age group (p < 0.001). There was a higher percentage of treatment by limited surgery among elderly patients with highly curable Stage IA and IB cancer with 26.6% having lumpectomy alone versus 9.4% in the younger patients. Five-year survival in that group was significantly worse (63%) than in patients treated by mastectomy (80%) or lumpectomy with axillary dissection and radiation (95%, < 0.001). A similar effect was seen in patients with Stage II cancer.
Breast cancer management appears compromised in elderly patients (older than 65 years of age). Frequency of mammography screening is significantly less in elderly women older than 65 years of age. Early detection of preinvasive (curative cancers) is significantly less than in younger patients. The recent requirement by Medicare of mammography every other year may further reduce the opportunity to detect potentially curable cancers. Approximately 20% of patients had inferior treatment of favorable stage early primary cancer with worsened survival. Detection and treatment strategy changes are needed to remedy these deficiencies.
关于老年患者乳腺癌治疗受到影响的观点促使我们回顾乳腺癌筛查和早期检测政策的结果,以及与年轻女性(40至64岁)相比老年女性(≥65岁)原发性治疗的充分性。
尽管老年患者的乳腺癌在生物学上被认为比年轻患者分期相同的癌症侵袭性小,但结果仍然取决于癌症分期和原发性癌症的充分治疗。由于多种原因,医生似乎不愿意按照用于年轻患者的相同标准治疗老年患者。甚至在早期检测项目中有政府规定的变更。因此,自1993年以来,医疗保险规定65岁以上的女性每两年进行一次乳腺钼靶筛查,而目前公认的标准是50岁以上的女性每年进行一次乳腺钼靶检查。作者利用州卫生部门和肿瘤登记数据,回顾了原发性乳腺癌老年患者的筛查实践和治疗情况,以确定年龄对筛查、检测政策(如诊断时的分期所示)、治疗策略和结果的影响。
分析了1987年至1995年罗德岛医院协会全州肿瘤登记处记录的5962例乳腺癌患者的数据。数据收集的重点是九个设有肿瘤登记处并使用美国癌症联合委员会(AJCC)分类肿瘤数据的机构。州卫生部门还提供了1987年、1989年和1995年2536名女性乳腺钼靶筛查实践的额外数据。
1987年、1989年和1995年所有患者的乳腺钼靶筛查频率平均分别为40%、52%和63%。在65岁及以上的患者中,1987年筛查频率为34%,1989年为45%,1995年为48%;而在40至49岁年龄组中,1987年乳腺钼靶检查频率为47%,1989年为61%,1995年为74%(p<0.00)。65岁及以上患者的原位癌检出率较低,为8.8%,而40至64岁年龄组患者为13.7%(p<0.001)。在IA期和IB期高度可治愈的癌症老年患者中,采用有限手术治疗的比例较高,26.6%的患者仅行肿块切除术,而年轻患者为9.4%。该组患者的5年生存率(63%)明显低于接受乳房切除术(80%)或肿块切除术加腋窝清扫和放疗的患者(95%,p<0.001)。II期癌症患者也有类似情况。
老年患者(65岁以上)的乳腺癌治疗似乎受到影响。65岁以上老年女性的乳腺钼靶筛查频率明显较低。原位癌(可治愈癌症)的早期检测明显低于年轻患者。医疗保险最近要求每隔一年进行一次乳腺钼靶检查,这可能会进一步减少发现潜在可治愈癌症的机会。约20%的患者对早期原发性癌症的有利分期治疗较差,生存率降低。需要改变检测和治疗策略以弥补这些不足。